Andrew R. Crescenzo
CIK 1363902 · Chief Financial Officer · last filed 2025-08-26
Andrew R. Crescenzo is a Chief Financial Officer who has filed 15 SEC Form 4 insider transactions across 2 companies since 2007. The most recent filing shows the insider bought $256.4K of STSSW on Aug 26, 2025. Across all open-market trades the lifetime net is +$279.2K, making them a net buyer over the disclosed history. Current disclosed insider exposure totals $1.4K across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$1.4K
2
15
$279.2K
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| STSSW | Chief Financial Officer | 40,000 | $0.03 | $1.4K | $279.2K | 7 | 2025-08-26 |
| ENZO BIOCHEM INC (ENZ) Delisted | Senior VP of Finance | 52,452 | $0.31 | $16.5K | $0 | 8 | 2014-01-22 |
Recent Filings
15 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2025-08-26 | STSSW | Buy (P) | +40,000 | $256.4K | EDGAR |
| 2024-04-30 | STSSW | Buy (P) | — | $0 | EDGAR |
| 2023-12-29 | STSSW | Buy (P) | +3,500 | $1.5K | EDGAR |
| 2023-01-27 | STSSW | Buy (P) | — | $0 | EDGAR |
| 2022-05-09 | STSSW | Buy (P) | +6,000 | $7.8K | EDGAR |
| 2022-05-05 | STSSW | Buy (P) | — | $0 | EDGAR |
| 2022-04-21 | STSSW | Buy (P) | +6,000 | $13.6K | EDGAR |
| 2014-01-22 | ENZO BIOCHEM INC (ENZ) Delisted | Grant (A) | — | $0 | EDGAR |
| 2013-12-18 | ENZO BIOCHEM INC (ENZ) Delisted | Disp (D) | −8,000 | -$19.3K | EDGAR |
| 2013-01-22 | ENZO BIOCHEM INC (ENZ) Delisted | Grant (A) | — | $0 | EDGAR |